Slingshot Insights | Arlz Overview

ARLZ Overview

Upcoming Projects (ARLZ)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (ARLZ)

Don’t see a project related to the company you care about? Create your own!

Expired Projects (ARLZ)

With a Fresh Approval Finally in Hand, What's the Market Potential For YOSPRALA in Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers
Ticker: ARLZ
Execute By: Sep 30, 2016

Upcoming & Overdue Catalysts (ARLZ)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (ARLZ)

Aralez Pharmaceuticals (ARLZ) commences full-scale commercial launch of former Merck (MRK) product Zontivity
Tickers: ARLZ, MRK
Occurred on: Jun 07, 2017
Aralez (ARLZ) Granted U.S Patent Covering Yosprala, the Only Fixed Dose Combination of Aspirin and Omeprazole
Ticker: ARLZ
Occurred on: Jan 11, 2017
FDA Approves Aralez Pharma's (ARLZ) YOSPRALA for Secondary Prevention of Cardiovascular and Cerebrovascular Events in Patients at Risk of Asprin-Induced Gastric Ulcers
Ticker: ARLZ
Occurred on: Sep 15, 2016

Strategic Initiatives (ARLZ)

Don’t see a strategic initiative related to the company you care about? Create your own!